February thla dongh ah Pfizer sin in a khoh 1nk COVID-19 kakuaisi kan ngah lai, tiah Malaysia ram hruaitu PM Muhyiddin Yassin nih a thanh.
“Kan ram Ngandamnak Vuanci Zung tangum Rampi Kakuaisi Upadi Zung nih Pfizer sermi COVID-19 kakuaisi cu hman dingin a cohlan cang.
“Kakuaisi kan ngah cangka in rianrang tein kan chunh khawh colhnak hnga, Ngandamnak Vuanci Zung nih ‘rammi COVID-19 kakuaisi chunhnak simanking’ a tuah cang.
“Kan ram ah COVID-19 zawtnak a thian khawhnak hnga, kan rammi 60% in 70% kar (20-23 million) tal cu kakuaisi chunh an hau.
“Atutiang ahcun, Pfizer le AstraZeneca company he min kan thut cang i kan rammi 40% caah kakuaisi ngah ding cu a fiang cang.
“Mah pinah, kakuaisi company dang; Sinovac, Cansino le Gamaleya zong cawk dingin kan hal hna lio asi. Kan ram milu 80% (26.5 million) tal kakuaisi chunh dingin kan i zuam cuahmah.
“Cun, China sermi kakuaisi zong kan rammi sinah kan hneksak cuahmah ve lio asi. January 21 in sizung 9 ah a donghnak bik khoh 3nak kan hneksak lai.
“Khoh 1nak ahkhan kan rammi minung 3,000 sinah kan hneksak. Mah kakuaisi hi ramdang ahcun kan ram hi minung tambik sinah a hneksakmi kan si. Kakuaisi cu Medical Biology Chinese Academy of Medical Services, China (Imbcams) nih a sermi si,” ati.
